Edges in Network
| Network | GSE23772_egf1520 - GSE23772 - SiGN-BN HC+Bootstrap |
| Network Description | Why does HAMLET preferentially kill tumor cells? p38-dependent death in tumor but up-regulation of innate immunity in healthy, differentiated cells |
| Node | RAC2 |
| Upstream (Parents) |
|---|
| (<<) IL1F7 → RAC2 |
| (<<) KRT34 → RAC2 |
| (<<) MMP7 → RAC2 |
| (<<) MT1G → RAC2 |
| (<<) PCDH7 → RAC2 |
| (<<) RGMB → RAC2 |
| (<<) SAA1 → RAC2 |
| (<<) TUBB2C → RAC2 |
| (<<) UBD → RAC2 |
| Downstream (Children) |
|---|
| RAC2 → ADORA2B (>>) |
| RAC2 → ANKRD37 (>>) |
| RAC2 → ANTXR1 (>>) |
| RAC2 → CASP4 (>>) |
| RAC2 → CCNE1 (>>) |
| RAC2 → CD3EAP (>>) |
| RAC2 → CDH3 (>>) |
| RAC2 → CEACAM1 (>>) |
| RAC2 → CITED4 (>>) |
| RAC2 → CKB (>>) |
| RAC2 → CSTB (>>) |
| RAC2 → DDR1 (>>) |
| RAC2 → E2F2 (>>) |
| RAC2 → F2RL1 (>>) |
| RAC2 → FGFR3 (>>) |
| RAC2 → GRK5 (>>) |
| RAC2 → HLA-A (>>) |
| RAC2 → MAP3K14 (>>) |
| RAC2 → MAPK1 (>>) |
| RAC2 → METRNL (>>) |
| RAC2 → MLKL (>>) |
| RAC2 → NFIA (>>) |
| RAC2 → NFIB (>>) |
| RAC2 → NNMT (>>) |
| RAC2 → PI3 (>>) |
| RAC2 → PLAUR (>>) |
| RAC2 → PLEK2 (>>) |
| RAC2 → RPL29 (>>) |
| RAC2 → S100A2 (>>) |
| RAC2 → SAA4 (>>) |
| RAC2 → SMAD3 (>>) |
| RAC2 → SPAG5 (>>) |
| RAC2 → WNT10A (>>) |
